tizanidine
- Product NDC
- 50090-0813
- 11-digit product format
- 500900813
- Labeler code
- 50090
- Product ID
- 50090-0813_cc61a2a7-697a-4c20-8edf-3846dfaae76a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2004-01-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-0813-0 | 50090081300 | 30 TABLET in 1 BOTTLE (50090-0813-0) | 30 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-0813-1 | 50090081301 | 60 TABLET in 1 BOTTLE (50090-0813-1) | 60 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |